Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Oncol. May 15, 2024; 16(5): 1869-1877
Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1869
Table 2 Univariate and multivariate analyses for overall survival in the training cohort
VariablesUnivariate analysis
P value
Multivariate analysis
P value
HR (95%CI)
HR (95%CI)
GenderMale1---
Female5.755 (0.660, 50.196)0.033--
Age≥ 751.745 (0.198, 15.416)0.064--
< 751---
ObstructionYes0.785 (0.035, 17.665)0.014--
No1---
CEA (ng/mL)> 51.576 (0.497, 4.994)0.434--
≤ 51---
CA199 (U/mL)> 3720.20 (1.881, 216.893)0.0026.315 (1.520, 26.243)0.011
≤ 371-1-
Surgical procedureLaparotomy1.586 (0.130, 19.331)0.012--
Laparoscopy1---
Right hemicolonYes2.873 (0.775, 10.656)0.0165.236 (1.229, 22.308)0.025
No1-1-
EnterostomyYes6.086 (1.949, 19.007)0.00013.302 (3.392, 52.171)0.000
No1-1-
Tumor size (cm)≥ 6.82.252 (0.376, 13.489)0.004--
< 6.81---
Poor differentiatedYes4.311 (1.341, 13.856)0.008--
No1---
T stageT4a1-1-
T4b8.241 (2.500, 27.158)0.00010.888 (2.809, 42.199)0.001
Lymph node count≥ 121---
< 121.143 (0.250, 5.225)0.863--
Regular reviewYes1-1-
No5.676 (1.534, 21.000)0.0034.626 (1.075, 19.905)0.040